UNSPSC 51383506: Pravadoline

This classification denotes a cyclooxygenase inhibitor with the molecular formula C23H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P3JW662TWA, chemically known as methanone, (4-methoxyphenyl)(2-methyl-1-(2-(4-morpholinyl)ethyl)-1h-indol-3-yl)- but generally known as pravadoline, which bears US NIH Compound Identifier 56463. European Medicines Agency schedules Pravadoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10003MIG.

UNSPSC 51383506 Pravadoline is a Commodity code that in state and local procurement covers the purchase of naloxone and related drug deactivation systems for public health and emergency response. State and local governments buy these products through competitive bidding processes to support community health initiatives and opioid-crisis response programs. Issuing bodies soliciting under this code include county health departments and public health authorities responsible for maintaining naloxone supplies and harm-reduction resources. The work involves product procurement with defined delivery schedules and vendor compliance requirements including drug-free workplace certification, E-Verify authorization, and insurance coverage for workers' compensation, commercial general liability, and professional liability.

Seminole County, Florida has posted recent activity under this code. In June 2026, Seminole County released IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023. Contracts under this solicitation carry a two-year initial term with an optional one-year renewal, and may include FEMA funding with associated federal compliance requirements. The source shows limited recent activity under this code; the single opportunity identified spans Florida and reflects typical state and local demand for opioid-response supplies.